Delivery Order SPE2DB20D3103-SPE2DB23FN3U8
- Not listed
- This federal contract award, worth $2,418.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order, is for the supply of Rizatriptan 5 mg orally disintegrating tablets. It is a firm-fixed-price contract with a performance period through May 19, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rizatriptan 10 mg oral disintegrating tablets in packs of 18. The total value of this award is $1,606.04, and it has an ultimate completion date of July 20, 2023. The contract is not designated with a set-aside requirement, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award is for the delivery of Rizatriptan 10 mg Oral Disintegrating Tablets (ODT) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., has a ceiling value of $1,327.60 and was issued as a Firm Fixed Price Delivery Order. The award was made on January 11, 2022, with a completion date of January 12, 2022. This contract was not designated as a set-aside and was awarded through full...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,184.82 firm fixed-price delivery order is for the supply of 18 units of the drug Rizatriptan 10 mg Orally Disintegrating Tablets. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, with a ceiling value of $3,430.05, is for the delivery of Rizatriptan 10 mg Tablet UD 18s, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a completion date of May 16, 2023. The...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,867.38 firm fixed-price delivery order covers the supply of 4,563,750,623 units of Rizatriptan 10 mg tablets for an ultimate completion date of February 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,020.31 firm-fixed-price delivery order contract is for the supply of Rizatriptan 10 mg orally disintegrating tablets. The contract has an ultimate completion date of December 16, 2024 and is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award is for the delivery of rizatriptan 5 mg orally disintegrating tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,505.84 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Rizatriptan 5 mg orally disintegrating tablets. The firm fixed price Delivery Order, valued at $8,509.62, has a completion date of June 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Rizatriptan 10 mg Orally Disintegrating Tablets to the Defense Logistics Agency (DLA). The Delivery Order has a ceiling value of $9,317.94 and is a Firm Fixed Price contract type with an ultimate completion date of April 18, 2023. The contract is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN3U8Delivery Order
This federal contract award, valued at $1,248.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Rizatriptan 10 mg orally disintegrating tablets (ODT). The award is a firm-fixed-price delivery order with an ultimate completion date of May 15, 2023. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as a primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/12/23 |